FMK Negative Control

• CAT Number: R061255
• CAS Number: 197855-65-5
• Molecular Formula: C₂₁H₂₃FN₂O₄
• Molecular Weight: 386.42
• Purity: ≥95%
• Synonyms: N-[(1S)-2-[(3-Fluoro-1-methyl-2-oxopropyl)amino]-2-oxo-1-(phenylmethyl)ethyl]-carbamic acid Phenylmethyl Ester; ?[1(S)]-[2-[(3-Fluoro-1-methyl-2-oxopropyl)amino]-2-oxo-1-(phenylmethyl)ethyl]-carbamic acid Phenylmethyl Ester
• Target: Metabolic Enzyme/Protease
• Storage: -20°C
• IUPAC Name: benzyl N-[(2S)-1-[(4-fluoro-3-oxobutan-2-yl)amino]-1-oxo-3-phenylpropan-2-yl]carbamate
• InChI: InChI=1S/C21H23FN2O4/c1-15(19(25)13-22)23-20(26)18(12-16-8-4-2-5-9-16)24-21(27)28-14-17-10-6-3-7-11-17/h2-11,15,18H,12-14H2,1H3,(H,23,26)(H,24,27)/t15?,18-/m0/s1
• InChIKey: ASXVEBPEZMSPHB-PKHIMPSTSA-N
• SMILES: CC(C(=O)CF)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)OCC2=CC=CC=C2

FMK Negative Control（Cat No.:R061255）is a synthetic compound designed to serve as a negative control in caspase activity assays. It lacks the reactive group required for the inhibition of caspases, ensuring that observed effects in experiments are not due to off-target activity. This control is crucial for verifying the specificity of caspase inhibitors and assessing the validity of experimental results. FMK Negative Control can be used in apoptosis-related studies to differentiate between actual caspase inhibition and non-specific effects, providing reliable experimental validation.